We're making headlines

We're on a mission to transform medical research, for good. And people are taking notice.

Press Release: "Precision Medicine for Me Aims to Bridge Emergent Divide in Cancer Care:  Helping Patients in Europe Realize the Full Potential of Breakthrough Cancer Technology"

Press Release: "Free to Breathe Partners With Antidote Technologies to Empower Patients to Find and Take Part in Lung Cancer Research"

iTech Post: "Lung Cancer: New Drugs Could Help Patients Live Longer"

Forbes: "Putting Me Into The Cancer Moonshot"

Tech City News: "5 UK Tech Firms Using AI to Transform Healthcare"

TechWorld: "13 UK Healthtech Startups to Watch: From Patient Apps to Genomics Startups"

Press Release: "Precision Medicine for Me Aims to Give All US Lung Cancer Patients Access  to Next-Generation Tumor Testing"

Press Release: "Multiple Sclerosis Association of America and Antidote Technologies Team Up  to Increase Awareness of Clinical Trials"

Press Release: "Improving Access To Clinical Trials: American Kidney Fund Adds User-Friendly Search Capability And Information To Kidneyfund.Org"

Applied Clinical Trials: "Antidote Incorporates Patient Centricity in Subject Enrollment"

Press Contact
media-kit-cta